Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

Clinical trial NCT01590979 · TERMINATED

Trial details

NCT number: NCT01590979
Sponsor: Northwell Health
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Atrial Fibrillation New Onset Hemorrhage Prolonged QTc Interval Ventricular Tachycardia Medical Care; Complications, Late Effect of Complications

Start date: 2012-04-01
Primary completion: 2015-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.